BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19740980)

  • 1. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.
    Le Tortorec A; Neil SJ
    J Virol; 2009 Nov; 83(22):11966-78. PubMed ID: 19740980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
    Gupta RK; Mlcochova P; Pelchen-Matthews A; Petit SJ; Mattiuzzo G; Pillay D; Takeuchi Y; Marsh M; Towers GJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20889-94. PubMed ID: 19864625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.
    Mack K; Starz K; Sauter D; Langer S; Bibollet-Ruche F; Learn GH; Stürzel CM; Leoz M; Plantier JC; Geyer M; Hahn BH; Kirchhoff F
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.
    Petit SJ; Blondeau C; Towers GJ
    J Gen Virol; 2011 Dec; 92(Pt 12):2937-2948. PubMed ID: 21900423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin.
    Giese S; Lawrence SP; Mazzon M; Nijmeijer BM; Marsh M
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32325729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.
    Goffinet C; Schmidt S; Kern C; Oberbremer L; Keppler OT
    J Virol; 2010 Nov; 84(21):11374-84. PubMed ID: 20702620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4
    Fernandez-de Céspedes MV; Hoffman HK; Carter H; Simons LM; Naing L; Ablan SD; Scheiblin DA; Hultquist JF; van Engelenburg SB; Freed EO
    J Virol; 2022 Dec; 96(23):e0087622. PubMed ID: 36354340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Feline Immunodeficiency Virus Envelope Signal Peptide Is a Tetherin Antagonizing Protein.
    Morrison JH; Poeschla EM
    mBio; 2023 Apr; 14(2):e0016123. PubMed ID: 36927083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages.
    Chu H; Wang JJ; Qi M; Yoon JJ; Chen X; Wen X; Hammonds J; Ding L; Spearman P
    Cell Host Microbe; 2012 Sep; 12(3):360-72. PubMed ID: 22980332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14
    Hoffman HK; Aguilar RS; Clark AR; Groves NS; Pezeshkian N; Bruns MM; van Engelenburg SB
    J Virol; 2022 Jul; 96(14):e0076722. PubMed ID: 35770989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells.
    Giese S; Marsh M
    PLoS Pathog; 2014 Jul; 10(7):e1004189. PubMed ID: 24991932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites.
    Grover JR; Llewellyn GN; Soheilian F; Nagashima K; Veatch SL; Ono A
    J Virol; 2013 Apr; 87(8):4650-64. PubMed ID: 23408603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Vpu protein: new concepts in virus release and CD4 down-modulation.
    Ruiz A; Guatelli JC; Stephens EB
    Curr HIV Res; 2010 Apr; 8(3):240-52. PubMed ID: 20201792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
    Blondeau C; Pelchen-Matthews A; Mlcochova P; Marsh M; Milne RS; Towers GJ
    J Virol; 2013 Dec; 87(24):13124-33. PubMed ID: 24067975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a different susceptibility of primate lentiviruses to type I interferons.
    Cordeil S; Nguyen XN; Berger G; Durand S; Ainouze M; Cimarelli A
    J Virol; 2013 Mar; 87(5):2587-96. PubMed ID: 23255800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
    Postler TS; Desrosiers RC
    J Virol; 2013 Jan; 87(1):2-15. PubMed ID: 23077317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production.
    Zhang Y; Ozono S; Yao W; Tobiume M; Yamaoka S; Kishigami S; Fujita H; Tokunaga K
    Sci Rep; 2019 Feb; 9(1):3134. PubMed ID: 30816279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF16B Mediates Anterograde Transport and Modulates Lysosomal Degradation of the HIV-1 Envelope Glycoprotein.
    Weaver N; Hammonds J; Ding L; Lerner G; Dienger-Stambaugh K; Spearman P
    J Virol; 2023 Jul; 97(7):e0025523. PubMed ID: 37358446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation.
    Lerner G; Ding L; Spearman P
    J Virol; 2023 Oct; 97(10):e0063123. PubMed ID: 37796124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules.
    Miranda LR; Schaefer BC; Kupfer A; Hu Z; Franzusoff A
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8031-6. PubMed ID: 12060749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.